1266:). Dr. Reddy's Laboratories sought the material for bioequivalency studies required to bring its own, generic, version of thalidomide to market. In response to the refusal, Dr. Reddy's Laboratories filed a Citizen's Petition with the FDA asking the Agency to adopt procedures that would ensure generic applicants the right to buy sufficient samples to perform bioequivalence testing of drugs that were subject to REMS distribution restrictions.
27:
215:
198:
181:
164:
1305:
1280:) to violate the anti-monopolization provisions of the Sherman Act. In early 2011, the district court denied Celgene's motion to dismiss. The case was set for trial beginning in February 2012, but the parties settled before the trial began, thereby postponing further judicial review of antitrust claims premised on alleged abuse of REMS distribution restrictions.
320:
In
December 2002, Celgene acquired Anthrogenesis, a privately held New Jersey-based biotherapeutics company and cord blood banking business, which is developing technology for the recovery of stem cells from placental tissues following the completion of full-term successful pregnancies. Anthrogenesis
660:
For the fiscal year 2017, Celgene reported earnings of US$ 2.539 billion, with an annual revenue of US$ 13.003 billion, an increase of 15.8% over the previous fiscal cycle. Celgene's shares traded at over $ 74 per share, and its market capitalization was valued at over US$ 51.8 billion in
November
475:
for $ 74 billion ($ 95 billion including debt), a deal that would become the largest pharmaceutical company acquisition ever. Celgene shareholders would receive one BMY share as well as $ 50 in cash for each
Celgene share held, valuing Celgene at $ 102.43 a share; representing a 54% premium to the
1269:
Celgene denied that it had behaved anti-competitively, arguing that the legislative history strongly suggested that
Congress considered and rejected a proposed guaranteed access procedure like the one proposed by Dr. Reddy's. Celgene further argued that requiring innovator companies to sell their
1288:
In July 2017, Celgene agreed to pay $ 280 million to government agencies to settle allegations that it caused the submission of false claims or fraudulent claims for non-reimbursable uses of its drugs
Revlimid and Thalomid to Medicare and state Medicaid programs. In its July 2017 10-Q, Celgene
652:. Effective June 30, 2017, Dr. Fouse will purportedly step down and be succeeded by Scott Smith, president of the company's Global Inflammation & Immunology Franchise, who joined the company in 2008. Dr. Fouse has been voted out by the board of directors on 2 April 2018.
412:
In June 2015, Celgene announced it had licensed
Lyceras RORgamma agonist portfolio for up to $ 105 million to develop its Phase I lead compound LYC-30937 for the treatment of inflammatory bowel disease. The licensing opportunity gave Celgene the option to acquire Lycera.
502:(BMS) announced that it has completed its acquisition of Celgene following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders.
2157:
345:
In June 2010, Celgene agreed to acquire
Abraxis BioScience. It purchased the biotechnology company for $ 2.9 billion in its expansion into drugs that attack solid tumors. Abraxis produced Abraxane, the cancer-fighting drug that can be given in high doses.
398:
entered into an agreement with
Celgene Corporation to discover and develop multispecific antibodies and antibody drug conjugates (ADCs). This followed the December 2012 collaboration between the two companies and focused on the field of immuno-oncology.
2574:
1208:
In June 2007, Celgene received full marketing authorization for
Revlimid in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy by the European Commission.
316:
In August 2000, Celgene acquired Signal
Pharmaceuticals, Inc., a privately held company that developed pharmaceuticals to regulate disease-related genes. Signal Pharmaceuticals was rebranded as Celgene Research San Diego.
1193:
In April 2000, Celgene reached an agreement with Novartis Pharma AG to license d-MPH, Celgene's chirally pure version of RITALIN. The FDA subsequently granted approval to market d-MPH, or Focalin, in November 2001.
1197:
In December 2005, Celgene received approval from the FDA to market Revlimid for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q
1007:
acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences
1229:
that binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). Ozanimod causes lymphocyte retention in lymphoid tissues. The mechanism by which ozanimod exerts therapeutic effects in
1698:
1148:
transfusion dependent anemia due to low or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5 q cytogenetic abnormality with or without additional cytogenetic abnormalities
1318:
1270:
products to potential generic competitors would violate its intellectual property rights and subject it to liability risks in the event that patients were harmed in Dr. Reddy's studies.
409:
That same month, Celgene announced it would acquire Quanticel for up to $ 485 million in order to enhance its cancer drug pipeline. Celgene had invested in Quanticel in April 2011.
1584:
1244:
Celgene develops several products within several areas of research (MM, MDS, AML, Lymphoma, CLL, Beta-Thalassemia, Myelofibrosis, Solid Tumors, Inflammation & Immunology.
1233:
is unknown, but may involve the reduction of lymphocyte migration into the central nervous system. Ozanimod is in development for immune-inflammatory indications including
1428:
1611:
2158:"NJDOT Clearing Out Abandoned Railway Property in Roselle Park; Union County to Apply For a Grant to Convert it into a Trail Through Roselle Park and Kenilworth"
2650:
2783:
2763:
2758:
1367:
2803:
2768:
1857:
1205:
In May 2006, Celgene received approval for Thalomid in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myeloma.
1190:
In July 1998, Celgene received approval from the FDA to market Thalomid for the acute treatment of the cutaneous manifestations of moderate to severe ENL.
372:
In January 2012, Celgene agreed to acquire Avila Therapeutics, Inc., a privately held biotechnology company for $ 925 million, with $ 350 million in cash.
416:
In July 2015, the company announced it would acquire Receptos for $ 7.2 billion in a move to strengthen the company's inflammation and immunology areas.
1532:
2231:
1808:
1960:
2793:
2698:
2263:
1783:
480:
opposed the deal, nominating five alternative potential directors on the Bristol-Myers board. The deal was approved by shareholders in April 2019.
2395:
429:
In January 2017, the company announced it would acquire Delinia for $ 775 million, increasing the company's autoimmune disease therapy offerings.
2798:
2030:
1273:
In 2018, Celgene was at the top of a list of companies that the FDA identified as refusing to release samples to competitors to create generics.
510:
The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):
1918:
2323:
1893:
1413:
1832:
2673:"United States Securities and Exchange Commission - Quarterly Report Puruant to Section 13 or 15 (d) of the Securities Exchange Act of 1934"
1748:
1586:
Plunkett's Biotech & Genetics Industry Almanac 2009: The Only Comprehensive Guide To Biotechnology And Genetics Companies And Trends
2778:
1226:
2451:
1978:
1875:
1455:
2549:
2524:
2499:
2651:"Celgene Agrees to Pay $ 280 Million to Resolve Fraud Allegations Related to Promotion of Cancer Drugs For Uses Not Approved by FDA"
1086:
1060:
336:, lenalidomide is only available through the a distribution network consisting of specialty pharmacies contracted by the company.
2808:
2290:
1946:
1351:
1723:
2813:
1323:
2575:"Analysis Showed Oral Ozanimod Reduced Brain Volume Loss Across All Age Subgroups in Adults with Relapsing Multiple Sclerosis"
2143:
1621:
1594:
1542:
1438:
1389:
1289:
disclosed that it resolved the matter in full for $ 315 million, including fees and expenses. The case was brought under the
2212:
2611:
1276:
Generic manufacturer Lannett Company initiated antitrust litigation that accused Celgene of using its REMS for THALOMID (
2356:
2005:
640:. Bob Hugin was succeeded in the CEO role by Mark Alles. At the same time, Jacqualyn Fouse was named as the company's
2635:
1942:
1347:
2672:
1202:
with or without additional cytogenetic abnormalities. Focalin XR was later launched by Celgene and Novartis in 2005.
1673:
1507:
957:
palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary
2054:
2788:
1121:
1558:
2753:
2097:
2239:
2479:
2735:
2773:
1259:
641:
2193:
2400:
1768:
1766:
Staff (January 1, 2014). "OncoMed, Celgene in $ 3.3B+ Cancer Stem Cell Collaboration". Industry Watch.
1222:
2597:
980:
the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate
273:
is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (
2116:"Abandoned Rahway Valley Railroad -Proposed Rails to Trails Route "Flyover" 🚂🚶🏼♂️👩🦼🚴🏼♀️"
2423:
1199:
975:
649:
645:
121:
432:
In January 2018, Celgene announced it would acquire Impact Biomedicines for $ 7 billion, adding
2079:
452:
1493:
375:
Citing a market capitalization of US$ 67 billion, and stock appreciation of 107%, Celgene was
1961:"Celgene, Agios, Launch $ 1B+ Metabolic Immuno-oncology Alliance - GEN News Highlights - GEN"
420:
1262:
requested, and Celgene refused to provide, a samples of Celgene's anticancer drug THALOMID (
451:
The company's Summit headquarters are located along the 7.3-mile main line of the abandoned
1368:
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
524:
499:
492:
472:
290:
238:
1858:"GEN - News Highlights:AstraZeneca Inks $ 1.8B in Immuno-Oncology Deals as Q1 Profit Dips"
8:
2475:
406:, worth $ 450 million, to study their Phase III immuno-oncology drug candidate MEDI4736.
1638:
2703:
1481:
1407:
1238:
1234:
1230:
1081:
1055:
909:
As of 2019, Celgene focused on oncology and immunology. Cancer drugs include Revlimid (
637:
354:
325:
306:
286:
115:
98:
1173:) treatment of multiple myeloma patients who have received at least one prior therapy
2364:
2331:
2298:
1646:
1617:
1590:
1538:
1463:
1434:
1395:
1385:
1117:
597:
440:
387:
1979:"Celgene buys EngMab for $ 600M and will head into clinic next year - FierceBiotech"
1943:"Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases"
1310:
1290:
362:
278:
207:
1328:
1039:
986:
963:
477:
395:
376:
366:
333:
111:
2653:. Department of Justice, U.S. Attorney’s Office, Central District of California
2031:"Celgene Bangs Out Deal Worth $ 775 Million for Kendall Square Startup Delinia"
1919:"Celgene Shells Out $ 82.5 Million in Cash for Portfolio, Option to Buy Lycera"
1613:
Bioactive Natural Products: Opportunities and Challenges in Medicinal Chemistry
455:. Some have advocated for the railbed's conversion to a pedestrian and cyclist
350:
233:
2232:"Celgene, Bristol-Myers set $ 2.2 billion termination fee for their mega deal"
2115:
1639:"Prominent Drug Chief to Sell Abraxis BioScience to Celgene for $ 2.9 Billion"
1382:
Die Biotechnologie-Industrie Ein Einführungs-, Übersichts- und Nachschlagewerk
2747:
2368:
2335:
2302:
2291:"Activist Investor Starboard Unhappy With Bristol-Myers' Deal to Buy Celgene"
1650:
1467:
1399:
1170:
1030:
358:
62:
45:
1164:
1143:
914:
910:
329:
274:
1894:"Celgene to funnel $ 45M into startup Quanticel for targeted cancer drugs"
1277:
1263:
1111:
1024:
1002:
456:
403:
495:
merger deal. The Bristol-Myers acquisition closed on November 20, 2019.
339:
In March 2008, Celgene acquired Pharmion Corporation for $ 2.9 billion.
918:
491:
drug programme from Celgene for $ 13.4 billion, as part of Celgene and
460:
433:
391:
310:
173:
37:
1319:
Biotech and pharmaceutical companies in the New York metropolitan area
921:) accounted for around 90% of the company's total revenue as of 2019.
2699:"Celgene to Pay $ 280 Million to Settle Fraud Suit Over Cancer Drugs"
2213:"Summit's own Highline would be 'crown jewel' in city's trail system"
1876:"GEN - News Highlights:Celgene to Acquire Quanticel for Up-to-$ 485M"
1809:"Celgene lands option to buy Sutro Bio in potential $ 1 billion deal"
952:
629:
2080:"Biotech M&A takes off as Sanofi and Celgene spend $ 20 billion"
419:
In May 2016, the company announced it would launch partnership with
2175:
2129:
1218:
1095:
1069:
520:
426:
In October 2016, the company acquired EngMab AG for $ 600 million.
302:
282:
148:
140:
136:
132:
2612:"F.D.A. Makes Public Generic-Blocking Practices of Drug Companies"
2324:"Bristol-Myers Shareholders Approve $ 74 Billion Deal For Celgene"
394:
and five other biologics from OncoMed's pipeline. That same year,
2083:
383:
144:
1724:"UPDATED: Celgene snaps up Avila Therapeutics in $ 925M buyout"
488:
471:
In January 2019, the company announced it would be acquired by
152:
51:
26:
2264:"Bristol-Myers to Buy Celgene in $ 74 Billion Cancer-Drug Bet"
1833:"Celgene-Sutro Cancer Antibody-ADC Partnership Grows to $ 1B+"
1033:) treatment of patients with newly diagnosed multiple myeloma
342:
In January 2010, Celgene acquired Gloucester Pharmaceuticals.
281:, and also in certain anemias. The company is incorporated in
484:
439:
Also in January 2018, the company announced it would acquire
190:
2144:"Park Line Pedestrian Bridge Officially Installed In Summit"
1784:"OncoMed, Celgene in $ 3.3B+ Cancer Stem Cell Collaboration"
436:, a kinase inhibitor with potential to treat myelofibrosis.
2396:"A Year into Job, Celgene President and COO Said to Retire"
2055:"Celgene to buy Impact Biomedicines for up to $ 7 billion"
1293:
by Beverly Brown, a former Celgene sales representative.
633:
505:
446:
2722:
1456:"Company News; Celgene, Thalidomide Maker, Adds Signal"
328:, as one of a group of pharmacies contracted to launch
249:
2176:"Union County Connects – A County Connected by Trails"
466:
402:
In April 2015, Celgene announced a collaboration with
1674:"Celgene to buy Abraxis BioScience for $ 2.9 billion"
1300:
2355:Kellaher, Jared S. Hopkins and Colin (2019-08-27).
1699:"Celgene opens new headquarters in UK | Pharmafile"
1370:, PM BMS, November 20, 2019; retrieved May 20, 2020
476:previous days closing price. The activist investor
2288:
1348:"Celgene Corporation 2018 Form 10-K Annual Report"
423:, developing metabolic immuno-oncology therapies.
1559:"McKesson Specialty certified to launch Revlimid"
1430:Oxford Dictionary of National Biography 2005-2008
636:, retired from his position and took the role of
324:In 2006, Celgene certified McKesson Specialty, a
309:of Celgene following the merger of Celanese with
2745:
2289:Lombardo, Cara; Maidenberg, Micah (2019-02-20).
2258:
2256:
1837:GEN - Genetic Engineering and Biotechnology News
1788:GEN - Genetic Engineering and Biotechnology News
1227:sphingosine 1-phosphate (S1P) receptor modulator
321:was rebranded as Celgene Cellular Therapeutics.
2098:"RVRR Main Line with landmarks in Union County"
1531:Atala, Anthony; Allickson, Julie (2014-12-01).
2357:"Bristol-Myers Moves Closer to Buying Celgene"
2210:
1530:
1384:(1. Aufl. 2016 ed.). Berlin, Heidelberg.
648:; Fouse had joined the company in 2010 as the
2253:
1582:
1363:
1361:
2784:Pharmaceutical companies based in New Jersey
2764:Biotechnology companies of the United States
2759:Pharmaceutical companies established in 1986
2452:"What Are Celgene's Key Sources of Revenue?"
2401:Genetic Engineering & Biotechnology News
2804:Biotechnology companies established in 1986
2769:Companies based in Union County, New Jersey
2648:
1609:
1089:(ADHD) in children, adolescents and adults
1412:: CS1 maint: location missing publisher (
1358:
1185:
379:'s number 2 ranked drug company of 2013.
2354:
1253:
1087:attention deficit hyperactivity disorder
1061:attention deficit hyperactivity disorder
349:In November 2011, Celgene relocated its
2794:Companies formerly listed on the Nasdaq
2476:"Drugs@FDA: FDA Approved Drug Products"
2321:
2006:"Celgene Could Be Bulking Up Very Fast"
2004:Lee, Armie Margaret (19 January 2018).
1947:U.S. Securities and Exchange Commission
1636:
1426:
1379:
1352:U.S. Securities and Exchange Commission
2799:American companies established in 1986
2746:
2696:
2609:
2229:
2194:"Abandoned right-of-ways Union County"
1324:Pharmaceutical industry in Switzerland
506:Company origin and acquisition history
2732:Historical business data for Celgene:
2638:. Baker Botts LLP. February 28, 2012.
2445:
2443:
2390:
2388:
2386:
2384:
1765:
1668:
1666:
447:US headquarters in Summit, New Jersey
277:), which is used in the treatment of
1453:
1283:
1082:dexmethylphenidate hydrochloride CII
1056:dexmethylphenidate hydrochloride CII
623:
2211:Barbara Rybolt (January 16, 2015).
2130:"The Summit Park Line: Latest News"
2003:
1534:Translational Regenerative Medicine
1063:(ADHD) in children and adolescents
467:Acquisition by Bristol-Myers Squibb
13:
2440:
2424:"Celgene Revenue 2006-2018 | CELG"
2381:
1663:
1340:
917:) and the immunology drug Otezla (
305:. In 1986, Celanese completed the
16:American biopharmaceutical company
14:
2825:
2779:1986 establishments in New Jersey
2714:
301:Celgene was originally a unit of
2449:
2322:Hopkins, Jared S. (2019-04-12).
1616:. World Scientific. p. 46.
1508:"Filed by Bowne Pure Compliance"
1427:Goldman, Lawrence (2013-03-07).
1303:
214:
213:
197:
196:
180:
179:
163:
162:
25:
2690:
2665:
2642:
2628:
2603:
2591:
2567:
2550:"Drugs@FDA: FDA-Approved Drugs"
2542:
2525:"Drugs@FDA: FDA-Approved Drugs"
2517:
2500:"Drugs@FDA: FDA-Approved Drugs"
2492:
2468:
2416:
2348:
2315:
2282:
2223:
2204:
2186:
2168:
2150:
2136:
2122:
2108:
2090:
2072:
2047:
2023:
1997:
1971:
1953:
1935:
1911:
1886:
1868:
1850:
1825:
1801:
1776:
1759:
1741:
1716:
1691:
1630:
1603:
1583:Plunkett, Jack W. (2008–2009).
1537:. Academic Press. p. 559.
1122:chronic myelomonocytic leukemia
487:announced it would acquire the
262:Footnotes / references
2809:1980s initial public offerings
2697:Thomas, Katie (25 July 2017).
2610:Teller, Sara E. (2018-05-29).
1637:Pollack, Andrew (2010-06-30).
1576:
1551:
1524:
1500:
1454:News, Bloomberg (2000-07-01).
1447:
1420:
1373:
1:
2814:2019 mergers and acquisitions
2649:Thom Mrozek (July 24, 2017).
1380:Schüler, Julia (2016-02-11).
1334:
1248:
928:
632:, the company's long serving
2480:Food and Drug Administration
2230:Mishra, Manas (2019-01-04).
2118:– via www.youtube.com.
1610:Brahmachari, Goutam (2012).
531:Signal Pharmaceuticals, Inc
7:
1433:. OUP Oxford. p. 289.
1296:
1212:
1116:treatment of patients with
904:
655:
549:Gloucester Pharmaceuticals
390:development agreement with
74:; 38 years ago
10:
2830:
1769:Gen. Eng. Biotechnol. News
1589:. Plunkett Research, Ltd.
1157:
1136:
1132:
1104:
1100:
1074:
1048:
1044:
1017:
995:
991:
968:
945:
365:which is also the home of
296:
941:
938:
935:
932:
929:
260:
244:
232:
222:
205:
188:
171:
158:
128:
105:
94:
86:
68:
58:
43:
33:
24:
1749:"Grading Pharma in 2013"
1260:Dr. Reddy's Laboratories
561:Avila Therapeutics, Inc
2180:unioncountyconnects.org
1200:cytogenetic abnormality
1186:Product-related history
976:melphalan hydrochloride
555:Abraxis BioScience Inc
384:OncoMed Pharmaceuticals
201:$ 35.480 billion (2018)
167:$ 15.281 billion (2018)
2789:Life sciences industry
2600:, retrieved 2019-05-12
2554:www.accessdata.fda.gov
2529:www.accessdata.fda.gov
2504:www.accessdata.fda.gov
493:Bristol-Myers Squibb's
453:Rahway Valley Railroad
289:, and a subsidiary of
218:$ 6.161 billion (2018)
184:$ 4.046 billion (2018)
2636:"Life Science Update"
1983:www.fiercebiotech.com
1254:Antitrust allegations
1169:(in combination with
1029:(in combination with
543:Pharmion Corporation
523:in 1986, acquired by
421:Agios Pharmaceuticals
388:stem cell therapeutic
382:In 2014, Celgene and
2754:Bristol Myers Squibb
1755:. December 31, 2013.
939:Date Approved (USA)
591:Impact Biomedicines
525:Bristol-Myers Squibb
500:Bristol-Myers Squibb
473:Bristol-Myers Squibb
291:Bristol Myers Squibb
239:Bristol Myers Squibb
2428:www.macrotrends.net
2404:. February 24, 2017
2361:Wall Street Journal
2328:Wall Street Journal
2295:Wall Street Journal
2146:. October 24, 2022.
1813:www.bizjournals.com
926:
285:, headquartered in
271:Celgene Corporation
224:Number of employees
21:
20:Celgene Corporation
2774:Summit, New Jersey
2704:The New York Times
2598:Celgene´s Pipeline
2242:on January 4, 2019
2086:. 22 January 2018.
1705:. 21 November 2011
1703:www.pharmafile.com
1643:The New York Times
1565:. 20 February 2006
1492:has generic name (
1460:The New York Times
1235:ulcerative colitis
1231:multiple sclerosis
925:Product Portfolio
924:
638:executive chairman
498:In November 2019,
478:Starboard Value LP
369:'s UK operations.
355:Windsor, Berkshire
353:headquarters from
326:specialty pharmacy
307:corporate spin-off
287:Summit, New Jersey
116:executive chairman
99:Summit, New Jersey
19:
2217:Independent Press
1945:(Press release).
1900:. 4 November 2011
1730:. 26 January 2012
1623:978-981-4335-37-9
1596:978-1-59392-124-8
1544:978-0-12-410457-0
1440:978-0-19-967154-0
1391:978-3-662-47160-9
1284:Fraud allegations
1183:
1182:
1118:refractory anemia
902:
901:
624:Executive history
614:
608:
602:
598:Juno Therapeutics
594:
588:
582:
576:
570:
564:
558:
552:
546:
540:
534:
528:
443:for $ 9 billion.
441:Juno Therapeutics
332:(Revlimid). As a
268:
267:
2821:
2726:
2725:
2723:Official website
2709:
2708:
2694:
2688:
2687:
2685:
2684:
2669:
2663:
2662:
2660:
2658:
2646:
2640:
2639:
2632:
2626:
2625:
2623:
2622:
2607:
2601:
2595:
2589:
2588:
2586:
2585:
2571:
2565:
2564:
2562:
2560:
2546:
2540:
2539:
2537:
2535:
2521:
2515:
2514:
2512:
2510:
2496:
2490:
2489:
2487:
2486:
2472:
2466:
2465:
2463:
2462:
2447:
2438:
2437:
2435:
2434:
2420:
2414:
2413:
2411:
2409:
2392:
2379:
2378:
2376:
2375:
2352:
2346:
2345:
2343:
2342:
2319:
2313:
2312:
2310:
2309:
2286:
2280:
2279:
2277:
2275:
2270:. 3 January 2019
2260:
2251:
2250:
2248:
2247:
2238:. Archived from
2227:
2221:
2220:
2208:
2202:
2201:
2190:
2184:
2183:
2172:
2166:
2165:
2154:
2148:
2147:
2140:
2134:
2133:
2126:
2120:
2119:
2112:
2106:
2105:
2094:
2088:
2087:
2076:
2070:
2069:
2067:
2066:
2051:
2045:
2044:
2042:
2041:
2027:
2021:
2020:
2018:
2016:
2001:
1995:
1994:
1992:
1990:
1985:. 3 October 2016
1975:
1969:
1968:
1957:
1951:
1950:
1949:. July 14, 2015.
1939:
1933:
1932:
1930:
1929:
1915:
1909:
1908:
1906:
1905:
1890:
1884:
1883:
1882:. 27 April 2015.
1872:
1866:
1865:
1864:. 24 April 2015.
1854:
1848:
1847:
1845:
1844:
1829:
1823:
1822:
1820:
1819:
1805:
1799:
1798:
1796:
1795:
1780:
1774:
1773:
1763:
1757:
1756:
1745:
1739:
1738:
1736:
1735:
1720:
1714:
1713:
1711:
1710:
1695:
1689:
1688:
1686:
1685:
1670:
1661:
1660:
1658:
1657:
1634:
1628:
1627:
1607:
1601:
1600:
1580:
1574:
1573:
1571:
1570:
1555:
1549:
1548:
1528:
1522:
1521:
1519:
1518:
1504:
1498:
1497:
1491:
1487:
1485:
1477:
1475:
1474:
1451:
1445:
1444:
1424:
1418:
1417:
1411:
1403:
1377:
1371:
1365:
1356:
1355:
1344:
1313:
1311:Companies portal
1308:
1307:
1306:
1291:False Claims Act
927:
923:
913:) and Pomalyst (
664:
663:
612:
606:
600:
592:
586:
580:
574:
568:
562:
556:
550:
544:
538:
532:
518:
483:In August 2019,
386:joined a cancer
363:Heathrow airport
311:American Hoechst
279:multiple myeloma
256:
253:
251:
217:
216:
210:
200:
199:
193:
183:
182:
166:
165:
82:
80:
75:
29:
22:
18:
2829:
2828:
2824:
2823:
2822:
2820:
2819:
2818:
2744:
2743:
2740:
2721:
2720:
2717:
2712:
2695:
2691:
2682:
2680:
2671:
2670:
2666:
2656:
2654:
2647:
2643:
2634:
2633:
2629:
2620:
2618:
2608:
2604:
2596:
2592:
2583:
2581:
2573:
2572:
2568:
2558:
2556:
2548:
2547:
2543:
2533:
2531:
2523:
2522:
2518:
2508:
2506:
2498:
2497:
2493:
2484:
2482:
2474:
2473:
2469:
2460:
2458:
2448:
2441:
2432:
2430:
2422:
2421:
2417:
2407:
2405:
2394:
2393:
2382:
2373:
2371:
2353:
2349:
2340:
2338:
2320:
2316:
2307:
2305:
2287:
2283:
2273:
2271:
2262:
2261:
2254:
2245:
2243:
2228:
2224:
2209:
2205:
2192:
2191:
2187:
2174:
2173:
2169:
2156:
2155:
2151:
2142:
2141:
2137:
2128:
2127:
2123:
2114:
2113:
2109:
2096:
2095:
2091:
2078:
2077:
2073:
2064:
2062:
2053:
2052:
2048:
2039:
2037:
2029:
2028:
2024:
2014:
2012:
2002:
1998:
1988:
1986:
1977:
1976:
1972:
1959:
1958:
1954:
1941:
1940:
1936:
1927:
1925:
1917:
1916:
1912:
1903:
1901:
1892:
1891:
1887:
1874:
1873:
1869:
1856:
1855:
1851:
1842:
1840:
1831:
1830:
1826:
1817:
1815:
1807:
1806:
1802:
1793:
1791:
1782:
1781:
1777:
1764:
1760:
1747:
1746:
1742:
1733:
1731:
1722:
1721:
1717:
1708:
1706:
1697:
1696:
1692:
1683:
1681:
1672:
1671:
1664:
1655:
1653:
1635:
1631:
1624:
1608:
1604:
1597:
1581:
1577:
1568:
1566:
1557:
1556:
1552:
1545:
1529:
1525:
1516:
1514:
1506:
1505:
1501:
1489:
1488:
1479:
1478:
1472:
1470:
1452:
1448:
1441:
1425:
1421:
1405:
1404:
1392:
1378:
1374:
1366:
1359:
1346:
1345:
1341:
1337:
1329:Sutro Biopharma
1309:
1304:
1302:
1299:
1286:
1256:
1251:
1239:Crohn's disease
1215:
1188:
1040:GlaxoSmithKline
987:GlaxoSmithKline
964:GlaxoSmithKline
907:
681:
676:
671:
658:
628:In March 2016,
626:
621:
611:RedoxTherapies
519:(Spun off from
508:
469:
449:
396:Sutro Biopharma
377:Forbes Magazine
367:GlaxoSmithKline
299:
264:
248:
225:
206:
189:
176:
151:
147:
139:
135:
119:
112:Robert J. Hugin
108:
78:
76:
73:
48:
17:
12:
11:
5:
2827:
2817:
2816:
2811:
2806:
2801:
2796:
2791:
2786:
2781:
2776:
2771:
2766:
2761:
2756:
2742:
2741:
2739:
2738:
2733:
2729:
2727:
2716:
2715:External links
2713:
2711:
2710:
2689:
2679:. 30 June 2017
2664:
2641:
2627:
2602:
2590:
2566:
2541:
2516:
2491:
2467:
2450:Team, Trefis.
2439:
2415:
2380:
2347:
2314:
2281:
2252:
2222:
2203:
2198:Google My Maps
2185:
2167:
2149:
2135:
2121:
2107:
2102:Google My Maps
2089:
2071:
2046:
2022:
1996:
1970:
1967:. 17 May 2016.
1952:
1934:
1910:
1885:
1867:
1849:
1824:
1800:
1775:
1758:
1740:
1715:
1690:
1662:
1629:
1622:
1602:
1595:
1575:
1550:
1543:
1523:
1499:
1446:
1439:
1419:
1390:
1372:
1357:
1338:
1336:
1333:
1332:
1331:
1326:
1321:
1315:
1314:
1298:
1295:
1285:
1282:
1255:
1252:
1250:
1247:
1246:
1245:
1242:
1214:
1211:
1187:
1184:
1181:
1180:
1177:
1174:
1167:
1162:
1156:
1155:
1152:
1149:
1146:
1141:
1135:
1134:
1131:
1130:
1127:
1124:
1114:
1109:
1103:
1102:
1099:
1098:
1093:
1090:
1084:
1079:
1073:
1072:
1067:
1064:
1058:
1053:
1047:
1046:
1043:
1042:
1037:
1034:
1027:
1022:
1016:
1015:
1012:
1009:
1005:
1000:
994:
993:
990:
989:
984:
981:
978:
973:
967:
966:
961:
958:
955:
950:
944:
943:
940:
937:
934:
931:
906:
903:
900:
899:
896:
893:
890:
887:
883:
882:
879:
876:
873:
870:
866:
865:
862:
859:
856:
853:
849:
848:
845:
842:
839:
836:
832:
831:
828:
825:
822:
819:
815:
814:
812:
809:
806:
803:
799:
798:
796:
793:
790:
787:
783:
782:
780:
777:
774:
771:
767:
766:
764:
761:
758:
755:
751:
750:
748:
745:
742:
739:
735:
734:
732:
729:
726:
723:
719:
718:
716:
713:
710:
707:
703:
702:
700:
697:
694:
691:
687:
686:
683:
682:in mil. USD$
678:
677:in mil. USD$
673:
672:in mil. USD$
668:
657:
654:
625:
622:
620:
619:
618:
617:
616:
615:
609:
595:
589:
583:
577:
571:
565:
559:
553:
547:
541:
537:Anthrogenesis
535:
512:
507:
504:
468:
465:
448:
445:
351:United Kingdom
334:specialty drug
298:
295:
266:
265:
258:
257:
246:
242:
241:
236:
230:
229:
226:
223:
220:
219:
211:
203:
202:
194:
186:
185:
177:
172:
169:
168:
160:
156:
155:
130:
126:
125:
109:
106:
103:
102:
96:
92:
91:
88:
84:
83:
70:
66:
65:
60:
56:
55:
49:
44:
41:
40:
35:
31:
30:
15:
9:
6:
4:
3:
2:
2826:
2815:
2812:
2810:
2807:
2805:
2802:
2800:
2797:
2795:
2792:
2790:
2787:
2785:
2782:
2780:
2777:
2775:
2772:
2770:
2767:
2765:
2762:
2760:
2757:
2755:
2752:
2751:
2749:
2737:
2734:
2731:
2730:
2728:
2724:
2719:
2718:
2706:
2705:
2700:
2693:
2678:
2674:
2668:
2652:
2645:
2637:
2631:
2617:
2613:
2606:
2599:
2594:
2580:
2576:
2570:
2555:
2551:
2545:
2530:
2526:
2520:
2505:
2501:
2495:
2481:
2477:
2471:
2457:
2453:
2446:
2444:
2429:
2425:
2419:
2403:
2402:
2397:
2391:
2389:
2387:
2385:
2370:
2366:
2362:
2358:
2351:
2337:
2333:
2329:
2325:
2318:
2304:
2300:
2296:
2292:
2285:
2269:
2265:
2259:
2257:
2241:
2237:
2233:
2226:
2218:
2214:
2207:
2199:
2195:
2189:
2181:
2177:
2171:
2163:
2159:
2153:
2145:
2139:
2131:
2125:
2117:
2111:
2103:
2099:
2093:
2085:
2081:
2075:
2060:
2056:
2050:
2036:
2032:
2026:
2011:
2007:
2000:
1984:
1980:
1974:
1966:
1962:
1956:
1948:
1944:
1938:
1924:
1920:
1914:
1899:
1898:FierceBiotech
1895:
1889:
1881:
1877:
1871:
1863:
1859:
1853:
1838:
1834:
1828:
1814:
1810:
1804:
1789:
1785:
1779:
1771:
1770:
1762:
1754:
1750:
1744:
1729:
1728:FierceBiotech
1725:
1719:
1704:
1700:
1694:
1679:
1675:
1669:
1667:
1652:
1648:
1644:
1640:
1633:
1625:
1619:
1615:
1614:
1606:
1598:
1592:
1588:
1587:
1579:
1564:
1560:
1554:
1546:
1540:
1536:
1535:
1527:
1513:
1509:
1503:
1495:
1483:
1469:
1465:
1461:
1457:
1450:
1442:
1436:
1432:
1431:
1423:
1415:
1409:
1401:
1397:
1393:
1387:
1383:
1376:
1369:
1364:
1362:
1353:
1349:
1343:
1339:
1330:
1327:
1325:
1322:
1320:
1317:
1316:
1312:
1301:
1294:
1292:
1281:
1279:
1274:
1271:
1267:
1265:
1261:
1243:
1240:
1236:
1232:
1228:
1224:
1220:
1217:
1216:
1210:
1206:
1203:
1201:
1195:
1191:
1178:
1175:
1172:
1171:dexamethasone
1168:
1166:
1163:
1161:
1158:
1153:
1150:
1147:
1145:
1142:
1140:
1137:
1133:
1128:
1125:
1123:
1119:
1115:
1113:
1110:
1108:
1105:
1101:
1097:
1094:
1091:
1088:
1085:
1083:
1080:
1078:
1075:
1071:
1068:
1065:
1062:
1059:
1057:
1054:
1052:
1049:
1045:
1041:
1038:
1035:
1032:
1031:dexamethasone
1028:
1026:
1023:
1021:
1018:
1013:
1010:
1006:
1004:
1001:
999:
996:
992:
988:
985:
982:
979:
977:
974:
972:
969:
965:
962:
959:
956:
954:
951:
949:
946:
933:Drug Name(s)
922:
920:
916:
912:
897:
894:
891:
888:
885:
884:
880:
877:
874:
871:
868:
867:
863:
860:
857:
854:
851:
850:
846:
843:
840:
837:
834:
833:
829:
826:
823:
820:
817:
816:
813:
810:
807:
804:
801:
800:
797:
794:
791:
788:
785:
784:
781:
778:
775:
772:
769:
768:
765:
762:
759:
756:
753:
752:
749:
746:
743:
740:
737:
736:
733:
730:
727:
724:
721:
720:
717:
714:
711:
708:
705:
704:
701:
698:
695:
692:
689:
688:
684:
679:
674:
669:
666:
665:
662:
653:
651:
647:
643:
639:
635:
631:
610:
604:
603:
599:
596:
590:
584:
578:
572:
566:
560:
554:
548:
542:
536:
530:
529:
526:
522:
517:
514:
513:
511:
503:
501:
496:
494:
490:
486:
481:
479:
474:
464:
462:
458:
454:
444:
442:
437:
435:
430:
427:
424:
422:
417:
414:
410:
407:
405:
400:
397:
393:
389:
385:
380:
378:
373:
370:
368:
364:
360:
359:Stockley Park
356:
352:
347:
343:
340:
337:
335:
331:
327:
322:
318:
314:
312:
308:
304:
294:
292:
288:
284:
280:
276:
272:
263:
259:
255:
247:
243:
240:
237:
235:
231:
227:
221:
212:
209:
204:
195:
192:
187:
178:
175:
170:
161:
157:
154:
150:
146:
142:
138:
134:
131:
127:
123:
117:
113:
110:
104:
100:
97:
93:
89:
85:
71:
67:
64:
63:Biotechnology
61:
57:
53:
50:
47:
42:
39:
36:
32:
28:
23:
2702:
2692:
2681:. Retrieved
2676:
2667:
2655:. Retrieved
2644:
2630:
2619:. Retrieved
2616:Legal Reader
2615:
2605:
2593:
2582:. Retrieved
2578:
2569:
2557:. Retrieved
2553:
2544:
2532:. Retrieved
2528:
2519:
2507:. Retrieved
2503:
2494:
2483:. Retrieved
2470:
2459:. Retrieved
2455:
2431:. Retrieved
2427:
2418:
2408:February 25,
2406:. Retrieved
2399:
2372:. Retrieved
2360:
2350:
2339:. Retrieved
2327:
2317:
2306:. Retrieved
2294:
2284:
2272:. Retrieved
2267:
2244:. Retrieved
2240:the original
2235:
2225:
2216:
2206:
2197:
2188:
2179:
2170:
2161:
2152:
2138:
2124:
2110:
2101:
2092:
2074:
2063:. Retrieved
2061:. 2018-01-08
2058:
2049:
2038:. Retrieved
2034:
2025:
2013:. Retrieved
2009:
1999:
1987:. Retrieved
1982:
1973:
1964:
1955:
1937:
1926:. Retrieved
1922:
1913:
1902:. Retrieved
1897:
1888:
1879:
1870:
1861:
1852:
1841:. Retrieved
1839:. 2014-10-23
1836:
1827:
1816:. Retrieved
1812:
1803:
1792:. Retrieved
1790:. 2013-12-03
1787:
1778:
1772:. p. 8.
1767:
1761:
1752:
1743:
1732:. Retrieved
1727:
1718:
1707:. Retrieved
1702:
1693:
1682:. Retrieved
1680:. 2010-06-30
1677:
1654:. Retrieved
1642:
1632:
1612:
1605:
1585:
1578:
1567:. Retrieved
1562:
1553:
1533:
1526:
1515:. Retrieved
1511:
1502:
1471:. Retrieved
1459:
1449:
1429:
1422:
1381:
1375:
1342:
1287:
1275:
1272:
1268:
1257:
1207:
1204:
1196:
1192:
1189:
1165:lenalidomide
1159:
1144:lenalidomide
1138:
1106:
1076:
1050:
1019:
997:
970:
947:
915:pomalidomide
911:lenalidomide
908:
680:Total Assets
659:
627:
515:
509:
497:
482:
470:
450:
438:
431:
428:
425:
418:
415:
411:
408:
401:
381:
374:
371:
348:
344:
341:
338:
330:lenalidomide
323:
319:
315:
300:
275:lenalidomide
270:
269:
261:
228:8,852 (2018)
208:Total equity
191:Total assets
120:Mark Alles (
95:Headquarters
90:Sol J. Barer
34:Company type
2736:SEC filings
2677:www.sec.gov
2579:celgene.com
1563:Drug Topics
1512:www.sec.gov
1490:|last=
1278:thalidomide
1264:thalidomide
1176:06-29-2006
1151:12-27-2005
1126:05-19-2004
1112:azacitidine
1092:05-26-2005
1066:11-13-2001
1036:05-25-2006
1025:thalidomide
1011:07-16-1998
1003:thalidomide
983:11-18-1992
960:01-17-1964
936:Indication
930:Brand Name
457:linear park
404:AstraZeneca
54:: CELG
2748:Categories
2683:2019-04-23
2621:2019-06-18
2584:2019-05-11
2559:21 October
2534:21 October
2509:21 October
2485:2007-09-03
2461:2019-11-09
2433:2018-11-05
2374:2020-03-30
2341:2019-04-23
2308:2019-04-23
2246:2019-04-23
2065:2020-03-30
2040:2020-03-30
1928:2020-03-30
1904:2020-09-23
1843:2020-03-30
1818:2020-03-30
1794:2020-03-30
1734:2020-03-26
1709:2020-09-13
1684:2022-06-22
1656:2020-03-26
1569:2020-09-13
1517:2022-06-22
1473:2020-01-22
1335:References
1249:Litigation
1077:Focalin XR
919:apremilast
685:Employees
675:Net income
613:(Acq 2016)
607:(Acq 2016)
601:(Acq 2018)
593:(Acq 2018)
587:(Acq 2017)
581:(Acq 2016)
579:EngMab AG
575:(Acq 2015)
569:(Acq 2015)
567:Quanticel
563:(Acq 2012)
557:(Acq 2010)
551:(Acq 2009)
545:(Acq 2008)
539:(Acq 2002)
533:(Acq 2000)
461:rail trail
434:fedratinib
392:demcizumab
174:Net income
107:Key people
38:Subsidiary
2369:0099-9660
2336:0099-9660
2303:0099-9660
2274:4 January
2268:Bloomberg
2015:4 January
2010:TheStreet
1989:4 January
1651:0362-4331
1482:cite news
1468:0362-4331
1408:cite book
1400:943795815
1258:In 2009,
953:melphalan
642:president
630:Bob Hugin
573:Receptos
46:Traded as
2657:July 27,
2035:BioSpace
1923:BioSpace
1297:See also
1219:Ozanimod
1213:Pipeline
1160:Revlimid
1139:Revlimid
1096:Novartis
1070:Novartis
1020:Thalomid
998:Thalomid
942:Partner
905:Products
656:Finances
605:AbVitro
585:Delinia
527:in 2019)
521:Celanese
303:Celanese
283:Delaware
149:Thalomid
141:Pomalyst
137:Abraxane
133:Revlimid
129:Products
59:Industry
2236:Reuters
2162:TAPinto
2084:Reuters
2059:Reuters
1678:Reuters
1179:
1154:
1129:
1051:Focalin
1014:
971:Alkeran
948:Alkeran
895:30,141
889:13,003
878:28,086
872:11,229
861:26,964
844:17,340
827:13,378
811:11,734
795:10,006
779:10,177
744:−1,534
670:Revenue
516:Celgene
361:, near
297:History
293:(BMS).
245:Website
159:Revenue
145:Imnovid
87:Founder
77: (
69:Founded
2456:Forbes
2367:
2334:
2301:
1753:Forbes
1649:
1620:
1593:
1541:
1466:
1437:
1398:
1388:
1221:is an
1107:Vidaza
898:7,467
892:2,940
881:7,132
875:1,999
864:6,971
858:1,602
855:9,256
847:6,012
841:2,000
838:7,670
830:5.100
824:1,450
821:6,494
808:1,456
805:5,507
792:1,318
789:4,842
773:3,626
763:5,389
757:2,690
747:4,445
741:2,255
731:3,611
725:1,406
715:2,736
699:1,258
661:2018.
489:Otezla
234:Parent
153:Idhifa
101:, U.S.
52:Nasdaq
886:2017
869:2016
852:2015
835:2014
818:2013
802:2012
786:2011
770:2010
754:2009
738:2008
722:2007
706:2006
690:2005
667:Year
485:Amgen
357:, to
2659:2017
2561:2021
2536:2021
2511:2021
2410:2017
2365:ISSN
2332:ISSN
2299:ISSN
2276:2019
2017:2019
1991:2019
1647:ISSN
1618:ISBN
1591:ISBN
1539:ISBN
1494:help
1464:ISSN
1435:ISBN
1414:link
1396:OCLC
1386:ISBN
1237:and
1223:oral
776:881
760:777
728:226
709:899
693:537
644:and
459:and
254:.com
252:.bms
79:1986
72:1986
1965:GEN
1880:GEN
1862:GEN
712:69
696:64
650:CFO
646:COO
634:CEO
250:www
122:CEO
2750::
2701:.
2675:.
2614:.
2577:.
2552:.
2527:.
2502:.
2478:.
2454:.
2442:^
2426:.
2398:.
2383:^
2363:.
2359:.
2330:.
2326:.
2297:.
2293:.
2266:.
2255:^
2234:.
2215:.
2196:.
2178:.
2160:.
2100:.
2082:.
2057:.
2033:.
2008:.
1981:.
1963:.
1921:.
1896:.
1878:.
1860:.
1835:.
1811:.
1786:.
1751:.
1726:.
1701:.
1676:.
1665:^
1645:.
1641:.
1561:.
1510:.
1486::
1484:}}
1480:{{
1462:.
1458:.
1410:}}
1406:{{
1394:.
1360:^
1350:.
1225:,
1120:,
463:.
313:.
2707:.
2686:.
2661:.
2624:.
2587:.
2563:.
2538:.
2513:.
2488:.
2464:.
2436:.
2412:.
2377:.
2344:.
2311:.
2278:.
2249:.
2219:.
2200:.
2182:.
2164:.
2132:.
2104:.
2068:.
2043:.
2019:.
1993:.
1931:.
1907:.
1846:.
1821:.
1797:.
1737:.
1712:.
1687:.
1659:.
1626:.
1599:.
1572:.
1547:.
1520:.
1496:)
1476:.
1443:.
1416:)
1402:.
1354:.
1241:.
143:/
124:)
118:)
114:(
81:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
